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Background: The cerebrovasuclar artery disease as a common complication of type-2 diabetes mellitus (T2DM)
caused huge economic burden and lives threatening to patients. We evaluated the prevalence and morphology of
carotid and cerebrovascular atherosclerotic plaques in T2DM patients with transient ischemic attack (TIA) or stroke
using multidetector CT (MDCT).
Methods: 64-MDCT and dual-source CT (DSCT) angiographies were performed in 195 T2DM patients with TIA or
stroke (mean age 65.7+/-12.8 years; 118 men) between January 2009 to August 2011. During the process, plaque
type, its distribution, extensive and obstructive natures were determined for each segment derived from the
patients.
Results: Atherosclerotic plaques were detected in 183 (93.8%) patients. A total of 1056 segments with plaque were
identified, of which 450 (42.6%) were non-calcified, 192 (18.2%) were mixed and 414 (39.2%) calcified ones. Among
them, 562 (53.2%) resulted in mild stenosis, 291 (27.6%) moderate stenosis, 170 (16.1%) severe stenosis and 33
(3.1%) occlusion. Non-calcified plaques contributed 91.8% to non-obstructive lumen narrowing, while mixed and
calcified plaques contributed 89.0% and 65.0% respectively.
Conclusions: MDCT angiography detected a high prevalence of plaques in T2DM patients with TIA or stroke. A
relatively high proportion of plaques were non-calcified, as well as with non-obstructive stenosis. MDCT
angiography might further enhance the detection and management of carotid and cerebrovascular atherosclerosis
in T2DM patients with TIA and strokeBackground
Currently, over 200 million individuals are known to
have diabetes mellitus (DM) worldwide and this number
is expected to double by the year 2025 [1]. Type-2 dia-
betes mellitus (T2DM) patients frequently have signifi-
cant carotid stenosis and multiple atherosclerotic
plaques, and have higher mortality rates, worse neuro-
logic outcome and more severe disability when they
suffer a stroke than those without diabetes [2-4]. Al-
though plaque morphology is not used in the decision
making of whether to perform carotid endarterectomy* Correspondence: hecicd@163.com
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reproduction in any medium, provided the oror not, it plays an important role, as it is directly
correlated with the risk of embolism and occlusion, thus
resulting in cerebral ischaemia (CI) [5]. Therefore, it
becomes more important to be able to predict the risk
of stroke based on the plaque prevalence and
morphology.
Conventional digital subtraction angiography (DSA) is
considered as the “gold standard” for the evaluation of
the degree of carotid and cerebrovascular artery stenosis,
but it is unable to make any predictions about plaque
type, and this time-consuming method remains invasive
and is still associated with catheter-related complications
[6]. Thus, several noninvasive imaging modalities such
as magnetic resonance imaging (MRI), multidetector
computed tomography (MDCT) and duplex ultrasoundThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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stenosis, and have been undergoing a rapid develop-
ment. To our knowledge, few studies systematically
investigated the characteristics of carotid and cerebro-
vascular plaque in T2DM patients with transient ische-
mic attack (TIA) or stroke by MDCT [7,8]. The purpose
of our study was to evaluate the prevalence and morph-
ology of carotid and cerebrovascular atherosclerotic
plaques in a large cohort of T2DM patients with TIA or
stroke by using MDCT angiography.
Methods
Study patients
From January 2009 to August 2011, we retrospectively
observed 195 consecutive T2DM patients (60.5% men,
mean age, 65.7 ± 12.8 years) with neurologic symptoms
of TIA or stroke at West China Hospital and Military
General Hospital of Chengdu PLA. The presenting
neurologic symptoms for all patients were classified as:
(1) transient symptoms, i.e., TIA or amaurosis fugax; (2)
prior stroke, i.e., any ischemic event with neurologic
symptoms. The exclusion criteria for MDCT were
known allergy for iodinated contrast agents, renal insuf-
ficiency (creatinine level ≥120 μmol/L), pregnancy, and
lack of lab or clinical data. All the MDCT examinations
were performed within 2 to 4 weeks of neurologic symp-
tom onset. All subjects gave informed consent, and the
Ethics Committees of West China Hospital and Military
General Hospital of Chengdu PLA approved the study.
Clinical data and diagnostic criteria
Baseline demographics and DM-ralated complications
were provided, such as age, gender, age at diabetes diag-
nosis, duration of DM, hypertension, duration of hyper-
tension, daily smoking, diabetic retinopathy (DR),
diabetic foot (DF), diabetic nephropathy (DN), atrial fib-
rillation (AF), myocardial infarction (MI), and CI. La-
boratory tests included measurement of fasting plasma
glucose (FPG), triglycerides (TG), total cholesterol (TC),
glycosylated hemoglobin (HbAlc), low-density lipopro-
tein cholesterol (LDL-C), and high-density lipoprotein
cholesterol (HDL-C). Hypertension was defined as sys-
tolic blood pressure of ≥140 mmHg or diastolic blood
pressure of ≥90 mmHg. DN was present if the 24-h
urinary albumin expression (24-h UAE UA1b) was
≥30 mg (normal, ≤30 mg) [9]. CI was confirmed by CT
or MRI.
CT protocols
Examinations were performed with 64-MDCT (Siemens
Medical Solutions, Forchheim, Germany) (n = 70, from
January 2009 to July 2010) at Military General Hospital of
Chengdu PLA, DSCT (SOMATOM Definition, Siemens
Medical Solutions, Forchheim, Germany) (n = 125, fromJuly 2010 to August 2011) at West China Hospital. For
the 64-MDCT group, examinations were performed with
the following parameters: 64 row × 0.5 mm detector colli-
mation, 0.5 s/gantry rotation, 120 kV, 350 mA, and 0.94
beam pitch. Unenhanced images were first obtained from
lower neck level to mid skull, which was used to deter-
mine the scan range of MDCT angiography. Injection of
90 ml of iodinated contrast agent (iopamidol, 370 mg of
iodine per milliliter; Bracco Sine Pharmaceutical Corp.
Ltd, Shanghai, China), immediately followed by 40 ml of
saline chaser solution, was administered through an 18-
gauge intravenous antecubital catheter at a flow rate
of 6 ml/sec with a dual-head power injector (Stellant;
Medrad, Indianola, Penn). DSCT examination was ob-
tained following standard protocols similar to conven-
tional 64-MDCT.
Image reconstructions were performed at 3D image
analysis workstation (Syngo-Imaging, Siemens, Medical
Solution System, Forchheim, Germany) with the
following parameters: a slice thickness of 0.75 mm, and
increment of 0.4 mm. The MDCT angiography reader
was permitted to utilize any or all of available
postprocessing image reconstruction algorithms, includ-
ing multiplanar reformat (MPR), curved planar reformat
(CPR), maximal intensity projection (MIP) or volume
rendered technique (VRT).
Imaging analysis
All data sets were assessed by two independent
observers unaware of the clinical history of the patients.
In cases where disagreement occurred, agreement was
reached in a joint reading.
According to the criteria of North American symp-
tomatic carotid endarterectomy trail (NASCET) [10], ca-
rotid and cerebrovascular arteries were divided into 40
segments including common carotid artery (CCA), ca-
rotid bifurcation (CB), external carotid arteries, internal
carotid arteries (ICA) (C1-C7), extracranial vertebral ar-
tery (eVA), intracranial vertebral artery (iVA), basilar ar-
tery (BA), anterior cerebral artery (A1, A2), middle
cerebral artery (M1, M2), posterior cerebral artery (P1,
P2), anterior communicating artery (ACoA), and poster-
ior communicating artery (PCoA). These segments were
also divided into 3 categories, including extracranial ar-
teries (CCA, CB, CA, C1, and eVA), intracranial ICA
(C2-C7), and intracranial arteries(iVA, BA, A1, A2, M1,
M2, P1, P2, ACoA, and PCoA). Only segments with a
diameter >1.5 mm (as measured on the MDCT angio-
gram) were included. The type of plaque was determined
using the following classification proposed by Ballotta E
et al. [11]: 1) non-calcified plaques, plaques having lower
density less than 50 HU; 2) calcified plaques, Plaques
with a mean attenuation of 130 HU or greater; and 3)
mixed plaques, plaques with a mean attenuation of 50-
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each chosen segment: grade 0 for normal or no observ-
able plaque, grade 1 for diameter stenosis <30%, grade 2
for 30%–69% diameter stenosis, grade 3 for plaques with
70%–99% diameter stenosis, and grade 4 for 100% occlu-
sion (Figure 1) [10]. Finally, it was determined whether
the plaque was obstructive or not, using a threshold of
70% luminal narrowing. Each vessel was analyzed on at
least two imaging planes, one parallel and one perpen-
dicular to the course of the vessel, and the vessel
diameters were measured on perpendicular to the vessel
course. For each patient the number of diseased
segments, type of plaque and degree of stenosis were
determined and recorded.
Statistical analysis
Continuous variables were expressed as means ± standard
deviation (SD). The categorical variables were presented
as numbers (percentages). All statistical analyses were per
formed using SPSS16.0 (SPSS Inc., Chicago, Ill). P < 0.05
was considered statistically significant.
Results
Patient characteristics
A carotid and cerebrovascular MDCT investigation was
performed in 195 patients and a total of 7368 artery
segments were included in the analysis, and 432 vascular
segments were excluded because of deficiency or diam-
eter <1.5 mm. There were significantly difference be-
tween men and women (60.5% vs. 39.5%, P < 0.05). AgeFigure 1 CPR images show different plaques and stenosis. A severe st
a mixed plaque. C mild stenosis caused by a calcified plaque.ranged from 41 to 89 years, with a mean age of 65.7 ±
12.8, and the duration of diabetes was 6.2 ± 5.4 years.
There was a high incidence of risk factors for athero-
sclerosis and associated diseases: 132 (67.7%) patients
were presented with hypertension, 126(64.6%) with CI,
and 67(34.4%) with a history of smoking. All clinical data
and laboratory test results are shown in Table 1.
Plaque prevalence and morphology
MDCT identified 183 (93.8%) and 12 (6.2%) patients
with and without cerebrovascular disease. A total of
1056 segments with plaque were identified. With regard
to plaque constitution, 450 (42.6%) of the plaques were
classified as non-calcified plaques, 192 (18.2%) as mixed
and 414 (39.2%) as calcified plaques (Figure 2). Among
these segments containing plaques, mild stenosis was
observed in 562 (53.2%) segments, moderate stenosis in
291 (27.6%) segments, severe stenosis in 170 (16.1%)
segments, and occlusion in 33 (3.1%) segments. In gen-
eral, eight hundred and fifty-three (80.8%) plaques
showed non-obstructive and 203 (19.2%) plaques showed
obstructive.
Plaque type and stenosis
There was different degree of stenosis in different
plaques. Non-calcified plaques resulted in mild (72.9%),
moderate (18.9%), severe stenosis (6.4%) and occlusion
(1.8%), mixed plaques resulted in mild (60.4%), moderate
(28.6%), severe stenosis (8.9%) and occlusion (2.1%), and
calcified plaques resulted in mild (28.5%), moderateenosis caused by a noncalcified plaque. B moderate stenosis caused by
Table 1 Clinical charcteristics of the study population
(N = 195)
Characteristics data
Age, years 65.7 ± 12.8
Men, n (%) 118(60.5)
Age at diabetes diagnosis, years 54.7 ± 11.4
Duration of diabetes, years 6.2 ± 5.4
Smoking, n (%) 67(34.4)
Duration of smoking, years 29.1 ± 12.2
Hypertension, n (%) 132 (67.7)
Duration of hypertension, years 10.3 ± 9.8
Fasting plasma glucose, mmol/L 7.3 ± 2.8
Triglycerides, mmol/L 1.7 ± 1.0
Total cholesterol, mmol/L 4.3 ± 0.9
High-density lipoprotein cholesterol, mmol/L 1.2 ± 0.3
Low-density lipoprotein cholesterol, mmol/L 2.3 ± 0.9
Serum uric acid, μmol/l 364.7 ± 103.1
Glycosylated hemoglobin,% 7.9 ± 2.1
Diabetic retinopathy, n (%) 55(28.2)
Diabetic foot, n (%) 25(12.8)
Diabetic nephropathy, n (%) 33(16.9)
Atrial fibrillation, n (%) 12(6.2)
Previous myocardial infarction, n (%) 41(21.0)
Cerebral infarction, n (%) 126(64.6)

















Figure 3 Bar graph demonstrating the difference of stenosis
between plaques.
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spectively. As shown in Figure 3, there was a trend that
non-calcified plaque resulted in a higher incidence of
non-obstructive lumen narrow and calcified plaque
resulted in a higher incidence of obstructive lumen nar-
row. In total, non-calcified, mixed and calcified plaques
mainly resulted in non-obstructive lumen narrowing,






Figure 2 Constitution of atherosclerosis plaques in T2DM
patients with TIA or stroke.Plaque distribution
The distributions of plaques were different, non-calcified
plaques mainly located in intracranial arteries (80.0%),
mixed plaques mainly in intracranial ICA (59.4%), and
calcified plaques mainly in intracranial ICA (64.5%) and
extracranial arteries (30.4%), as shown in Figure 4. The
most common site of all detectable plaques in patients
was the cavernous segment of ICA (213/1056, 20.2%),
followed by clinoid segment (130/1056, 12.3%) and ca-
rotid bifurcation (108/1056, 10.2%).
Discussion
In our study, only T2DM patients were enrolled, lack of
control group of non-diabetic patients, and the main
findings could be summarised as follows: Firstly, in
T2DM patients with TIA or stroke, relatively high
proportions of plaques were non-calcified and calcified,
mainly resulted in non-obstructive stenosis. Secondly,
the distributions of plaques were different, non-calcified
plaques mainly located in intracranial arteries, both
mixed and calcified plaques mainly in intracranial ICA.
Finally, the distribution of plaques was extensive, and
the most common site of plaque was the cavernous seg-
ment of ICA.
In the present study, 42.6% of the plaques are classi-
fied as non-calcified plaques, 18.2% as mixed and 39.2%
















Figure 4 Bar graph showing the distributions of plaques.
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calcified plaques and significantly less mixed plaques
than those without diabetes. Accordingly, these
observations could suggest a more rapid development of
atherosclerosis in the presence of diabetes, with faster
progression from non-calcified lesions to completely cal-
cified lesions [12]. A faster progression of atherosclerosis
had also been suggested previously on the basis of event
rates in patients with diabetes undergoing nuclear perfu-
sion imaging [13]. Interestingly, a recent study using
MDCT demonstrated that higher proportion of mixed
plaque was found in the subjects with diabetes than
those without diabetes [8]. But the number of study
subjects was small and they were all asymptomatic for
cardiac-related symptoms. There is no clear explanation
for this difference. It will probably take a larger pro-
spective study to resolve these discordant conclusions.
But, despite many controversies, our findings are of clin-
ical importance, since non-calcified plaque may be vul-
nerable to trigger plaque rupture or embolism [14], and
may be related to the high cerebrovascular disease mor-
tality and morbidity in T2DM patients with TIA or
stroke.
Symptomatic patients with carotid stenosis will benefit
from carotid endarterectomy or stenting as secondary
prevention of ischemic stroke [15], thus precise carotid
and cerebrovascular stenosis quantification is essential.
In our study, T2DM patients with TIA or stroke have an
obviously higher prevalence of non-obstructive lesions
(80.8%), in keeping with previous noninvasive and inva-
sive studies [1,16,17]. In a study about coronary artery
disease and plaque morphology using 64-MDCT, Scholte
et al. [1] revealed that plaques of T2DM patients were
mainly non-obstructive (82%). A similar relation be-
tween diabetes and non-obstructive plaques has been
shown by using invasive coronary angiography in the
study of Saely et al. [16]. It has been suggested that non-
obstructive plaque is more vulnerable and plaque rup-
ture may occur frequently [16,18,19], which may be
related to the high mortality and morbidity in T2DM
patients with TIA or stroke, and detection of an
increased non-obstructive plaque burden using MDCT
angiography may therefore be of clinical importance.
We also find that the distributions of plaques are differ-
ent: non-calcified plaques mainly located in intracranial
arteries (80.0%), mixed plaques mainly in intracranial ICA
(59.4%), and calcified plaques mainly in intracranial ICA
(64.5%) and extracranial arteries (30.4%). Because non-
calcified plaques was considered as vulnerable plaques
[19], and mainly located in intracranial arteries, it might
partly explain the increased cerebrovascular events in
T2DM patients with TIA or stroke, and therefore more
aggressive treatment of risk factors in these patients
merited further evaluation. Chen et al. [20] reported thatthe highest prevalence of calcification was seen in the left
and right ICA, at about 60%, followed by the right and left
vertebral artery, at about 20%. But their study had some
limitations. Firstly, the study technology was 16-MDCT.
Secondly, the FOV detected was from the skull base to
the vertex, not including the carotid. Thirdly, this study
included all the patients referred to hospital for brain CT
imaging, and only 19.0% patients with a history of dia-
betes. Furthermore, this was a non-contrast cross-
sectional investigation, and could not find non-calcified
and mixed plaques.
Additionally, when considering the distribution of
plaques, we find that the most common site of plaque is
the cavernous portion of ICA in T2DM patients with
TIA or stroke. Fields et al. [21] reported that stenosis of
the intracranial ICA was less common, and was usually
located between the carotid canal and the origin of the
ophthalmic artery. Wojak et al. [22] also revealed that
intracranial atherosclerotic stenosis typically occurred in
the petrous cavernous siphon segments of the ICA.
Masuoka et al. [23] explored the cause of development
of atheromatous plaque around the cavernous portion of
the ICA using serial 3-mm sections of 32 intracranial
ICAs obtained from 50 cadavers, and found that the ex-
ternal elastic lamina disappeared in the cavernous por-
tion of the ICA, and intimal thickening of the ICA
frequently appeared in the horizontal segment of the
cavernous portion of the ICA, which was the most com-
mon site of stenosis of the intracranial ICA. They
suggested that change in the elasticity of the arterial wall
in the cavernous portion might be an important factor
in the process of atherosclerosis in the intracranial ICA.
Outlining the significance of our study, the prevalence
and morphology of carotid and cerebrovascular athero-
sclerotic plaques in T2DM patients with TIA or stroke
by 64-MDCT and DSCT angiography is reported com-
prehensively and systematically. Secondly, the unique-
ness of our study lies in the scanner technology, which
has better visualization of arteries with calcified plaque
or vessels located next to the skull bone than early CT
[24,25]. In the present study, bone-subtraction CTA was
simple and user-independent, and thereby it was more ac-
ceptable for routine clinical work than other noninvasive
angiographies. Ultrasound analysis still remained user
dependent, for example, and Corriveau et al. [26] reported
that interobserver variability of Doppler sonography in
analysis of degree of stenosis was suboptimal. Thirdly, the
MDCT angiography findings, which depend on a large
study sample, can reflect relatively accurate characteristics
of plaque and stenosis in T2DM patients with TIA or
stroke, and can be used to conduct a further treatment
plan.
Limitations are there. Firstly, only T2DM patients
were studied, lack of a control group of non-T2DM
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sclerosis as determined by MDCT in larger populations
are needed. Secondly, the capabilities of current gener-
ation CT in the evaluation of disease involving small and
very small arteries with an average diameter of 1.5 mm
or less have not been well characterized. Finally, MDCT
is still associated with a risk of radiation dose, and ad-
ministration of contrast media is also required.
Conclusion
MDCT angiography detected a high prevalence of plaques
in T2DM patients with TIA or stroke. A relatively high
proportion of plaques were non-calcified, as well as with
non-obstructive stenosis. MDCT angiography might fur-
ther enhance the detection and management of carotid
and cerebrovascular atherosclerosis in T2DM patients
with TIA and stroke.
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